These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28096917)

  • 1. Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound.
    Billia M; Siddiqui KM; Chan S; Li F; Al-Zahrani A; Gomez JA; Chin JL
    Can Urol Assoc J; 2016; 10(11-12):416-422. PubMed ID: 28096917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience.
    Collins K; Brocken E; Bahler CD; Alabd A; Koch MO; Cheng L
    Hum Pathol; 2022 Jan; 119():79-84. PubMed ID: 34801600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue.
    Ryan P; Finelli A; Lawrentschuk N; Fleshner N; Sweet J; Cheung C; van der Kwast T; Evans A
    J Clin Pathol; 2012 Aug; 65(8):729-34. PubMed ID: 22659332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
    Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
    Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
    Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
    Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
    J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
    Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
    Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.
    Gelet A; Chapelon JY; Poissonnier L; Bouvier R; Rouvière O; Curiel L; Janier M; Vallancien G
    Urology; 2004 Apr; 63(4):625-9. PubMed ID: 15072864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
    Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
    Rouvière O; Sbihi L; Gelet A; Chapelon JY
    Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.